Efrat Dotan, MD
The Hematology-Oncology Fellowship Program is approved by the American Board of Internal Medicine.
The Department of Hematology/Oncology offers a three-year fellowship for internists who have completed an approved US residency program. The fellowship combines the resources of Temple University Hospital and Fox Chase Cancer Center. This combined hematology/oncology fellowship is certified by the American Board of Internal Medicine and the Accreditation Council for Graduate Medical Education. Each year, up to five new trainees are accepted into the program.
James Luke Godwin, MD *
Rishi Jain, MD
Hayley Knollman, MD
Raji Shameem, MD
Carlyn Tan, MD
Trent Wang, DO
James Gerson, MD
Pooja Ghatalia, MD
Adam Goldrich, MD
Chethan Ramamurthy, MD
Chad Smith, MD
Fern Anari, MD
Vineela Kasireddy, MD
Yang Liu, MD
James Martin, MD
Asya Varshavsky, MD, PhD
The First Two Years
The emphasis of the first two years is on clinical training. Twelve months total are spent at Fox Chase Cancer Center (6 in first year and 6 in second year). During this year, fellows are exposed to all aspects of medical oncology care. Fellows longitudinally follow their own patients in continuity clinics over the course of this clinical experience. Each fellow has separate clinics where they take care of breast cancer patients, lung cancer patients and GI cancer patients, respectively, under the tutelage of attending physicians who are nationally and internationally recognized for their expertise. There is a fourth half day of clinic consisting of one of the following: malignant hematology, sarcoma, genitourinary, head and neck, or gynecologic malignant diseases. Many of these disease-oriented clinics are multimodality in conjunction with surgical and/or radiation oncology services. There is an emphasis on exposure to the design and conduct of clinical research protocols. A number of interdisciplinary conferences and journal clubs in all of the above-named disease sites, as well as courses in biostatistics and basic science are available for fellows. Rotations in supportive oncology expose fellows to pain management and end-of-life issues, which are integral components of cancer care. Fellows also rotate through the family risk assessment and genetic counseling program.
The other 12 months of clinical training during the first two years occur at Temple University Hospital (6 during first year and 6 during second year). At this location, fellows have exposure to all aspects of hematology, both benign and malignant. Temple is a recognized leader in the field of coagulation research. A general oncology experience is also provided. Fellows also rotate through the bone marrow transplant service. This unit performs marrow, peripheral blood stem cell, auto- and allogeneic transplants, as well as matched unrelated donor and mismatched allogeneic transplants. Exposure to new technology, such as non-myeloablative allogeneic transplants, also is provided. There are full-time faculty members dedicated to the transplant program.
The first two years also allows for protected time for fellows to begin to engage in research; in fact, two months at Temple University are dedicated to research. In addition, second year fellows at Fox Chase have reduced clinical responsibility to have ample time for research, either in clinical investigation, outcomes research or a laboratory experience.
The Third Year
The focus of the third year of the fellowship training is flexible to match the overall career goals of the trainee. For fellows dedicated to a clinical investigator research career, fellows will typically have >75% of their time protected for this endeavor while having 1-2 continuity clinics, which can round out their training. Fellows interested in laboratory research will have one continuity clinic, with the remainder of time protected for laboratory research. For those fellows interested in a career in practice, the year will generally consist of 3-4 clinics to round out their clinical exposure. This flexibility allows fellows to make the most of this year of training to set the foundation for the beginning of their independent careers.
Applicants should be eligible for a Pennsylvania medical license, and should have completed an approved internal medicine residency in the US. Interviews will be conducted in late summer and fall of each academic year.
Apply for the Temple University Hospital/Fox Chase Cancer Center Hematology/Oncology Fellowship Program through the Electronic Residency Application Service (ERAS) at http://www.aamc.org/.
Our fellowship program also participates in the National Resident Matching Program (NRMP) Fellowship Match for fellowships starting July 1st. Below are the required documents:
- ERAS Common application form
- Current curriculum vitae
- Personal statement
- Minimum of three letters of recommendation, one of which should be from the residency department chairman or program director
- USMLE transcript
- H1B and J1 visas are accepted provided they cover the period of your fellowship training.
- Five positions are available.
- Research experience is not a requirement but will strengthen your application.
- The program provides both clinical and laboratory research.
- Applications that become complete after August 15th may not receive full consideration. Interviews will start in late August.
Contact and Address
Efrat Dotan, MD
Jessica Bauman, MD
Associate Program Director
GME Senior Program Administrator
Department of Hematology/Oncology
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497